Navigation Links
Europe in Biological Technology

Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)

THOUSAND OAKS, Calif. and LONDON, July 27 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN ) and GlaxoSmithKline (GSK) today announced a collaboration in which the companies will share commercialization of Amgen's monoclonal antibody denosumab for postmenopausal osteoporosi...

Amylin Pharmaceuticals to Present at Piper Jaffray Europe Conference

SAN DIEGO, June 17 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) will be presenting at the Piper Jaffray Europe Conference in London on Wednesday, June 24, 2009 at 10:30 a.m. British Summer Time/ 5:30 a.m. ET. Daniel M. Bradbury, president and chief executive officer o...

New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives

Three-of-Four Patients Surveyed Experience Daily Pain From Rheumatoid Arthritis Despite Current Treatment; Findings Unveiled at the European League Against Rheumatism Annual Congress of Rheumatology COPENHAGEN, Denmark, June 10 /PRNewswire-FirstCall/ -- Results from the Rheumatoid Arthritis: ...

OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice President, Europe & Asia/Pacific

OMNICOMM CONTINUES ITS EXPANSION INTO EUROPE AND STRENGTHENS ITS SENIOR MANAGEMENT TEAM FT. LAUDERDALE, Fla., May 12 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today anno...

ZyGEM Corp. and VWR International Europe BVBA Sign Agreement to Distribute Breakthrough DNA Extraction Technology in Europe

- Extends Successful Existing Distribution Agreement for the Americas - - The Agreement for Europe Will Ensure Researchers Can Easily Access ZyGEM's Growing Line of DNA Extraction Kits - - ZyGEM's Technology Enables Lower-Cost DNA Extraction and Is Ideally Suited to Automation and High-T...

Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site

PRINCETON, N.J., March 13 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD ) announced today that it is expanding its clinical pharmacology footprint in Europe with the acquisition of Swiss Pharma Contract, a 50-bed clinical research company based in Basel, Switzerland. "Our clients' need ...

Campbell Alliance Brand Management Practice to Present at EyeForPharma's Oncology Summit USA and Oncology Market Access Europe Conference

RALEIGH, N.C., March 10 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that Ashwin Dandekar, Vice President, Brand Management Practice, will present a session at EyeforPharma's Oncology Summit USA...

Physicians in Europe Rate Novartis #1 on Service Delivery, While Merck Earns Top Honors in the US

Even Among Companies Doing Well, Relationships Weaken in Many Countries NEW YORK, Feb. 17 /PRNewswire/ -- New TNS Healthcare research shows that physicians in four out of the five major European countries -- the UK, Germany, Spain and Italy -- give Novartis top marks for effectively deliverin...

New Biologic STELARA(TM) Receives Approval in Europe for Treatment of Moderate to Severe Plaque Psoriasis

First and Only Biologic Approved with Infrequent, Every Twelve-Week Maintenance Dosing BEERSE, Belgium, Jan. 22 /PRNewswire/ -- Janssen-Cilag announced today that STELARA(TM) (ustekinumab), the first in a new class of biologics, has been approved by the European Commission for use across Eu...

Seasonal Influenza Activity Increasing Across Europe - H3N2 Dominant Strain

BASEL, Switzerland, January 19 /PRNewswire-FirstCall/ -- - Tamiflu Remains Fully Effective Against 94 Percent of Circulating Influenza Viruses in Europe Latest surveillance data coming through the European Centre for Disease Prevention and Control (ECDC) from virologists and clin...

Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate

SAN MARINO, Calif., Dec. 16 /PRNewswire/ -- Epeius Biotechnologies Corporation, a leader in tumor-targeted gene delivery systems, has received two additional European patents for the platform targeting technologies and molecular designs that enable precision gene delivery to primary cancers and me...

CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East

NEWNAN, Ga., Dec. 3 /PRNewswire/ -- CeloNova BioSciences, Inc., announced today that it has expanded the areas in which it is commercializing the CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F -- a stent system that has not had any stent thrombosis in clinical studies. It is CE Mark...

EntreMed to Present at BioPartnering Europe Conference

ROCKVILLE, Md., Oct. 10 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD ) a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced today that Thomas H. Bliss, Jr., EntreMed's Senior Vice President, Corporate and Bu...

Totoku Europe Chooses Matrox Xenia(TM) Series to Drive Medical Monitors

MONTREAL, Oct. 8 /PRNewswire/ -- Matrox Graphics Inc., the leading manufacturer of specialized graphics solutions, confirms that Totoku Europe will be shipping Matrox Xenia(TM) Series display controller boards with its ME/CCL medical LCD displays. Matrox Xenia is the first native PCI Express...

BioMS Medical to present at Sachs Associates Biotech in Europe Forum

Toronto Stock Exchange Symbol: MS EDMONTON, Sept. 19 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Tony Hesby, Executive Vice President, Corporate Affairs, will present at the Sachs Associates ...

Quark Pharmaceuticals Announces Poster Presentations at RNAi Europe 2008

FREMONT, Calif., Sept. 17 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced the presentation of posters at the 5th Annual RNAi Europe, taking place September 16-18...

CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group

- Upfront, milestone payments and promotional investment totaling up to $385 million plus royalties - PALO ALTO, Calif., Sept. 12 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX ) announced today that it has entered into an agreement granting exclusive rights...

Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification

SAN DIEGO, July 14 /PRNewswire-FirstCall/ -- Cardium Therapeutics (Amex: CXM ) and its operating unit InnerCool Therapies, Inc., announced today that InnerCool's RapidBlue(TM) endovascular temperature modulation system conforms to the European Union CE Mark requirements for use in inducing, m...

Medicsight to Present at Piper Jaffray Annual Europe Conference

NEW YORK, June 23 /PRNewswire-FirstCall/ -- Medicsight PLC, a subsidiary of MGT Capital Investments, Inc. (Amex: MGT ), and an industry leader in the development of Computer-Aided Detection (CAD) and image analysis software, today announces that Allan Rowley (CFO) and Lucan Toh (Director of B...

deCODE genetics to Webcast Presentation at Piper Jaffray Europe Conference

REYKJAVIK, Iceland, June 19 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN ) today announced that it will host a live webcast of deCODE CEO Kari Stefansson's presentation at the Piper Jaffray Europe Conference. The presentation will be delivered on Wednesday, June 25, at 7am Easter...

Exelixis Announces June 25 Webcast of Presentation at the Piper Jaffray Europe Conference

SOUTH SAN FRANCISCO, Calif., June 18 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL ) announced today that Frank Karbe, executive vice president and chief financial officer at Exelixis, will present at the Piper Jaffray Europe Conference at 3:40 a.m. PT/6:40 a.m. ET/11:40 a.m. London,...

Novavax CEO to Present at Piper Jaffray Europe Conference, London, UK

ROCKVILLE, Md., June 16 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer, will be presenting at the Piper Jaffray Europe conference at 11:20 am. (GMT) on June 24, 2008 at The...

Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus

SAN DIEGO, May 28 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO ) announced today that the Company has launched in Europe its APTIMA(R) HPV Assay, a highly specific molecular diagnostic test to detect high-risk strains of the human papillomavirus (HPV), which causes cervical ...

Top Cancer Hospitals in Denmark and Netherlands First in Europe to Treat Patients With RapidArc(TM) Radiotherapy

New technology from Varian Medical Systems delivers faster image-guided intensity-modulated radiotherapy (IMRT) to target tumors while sparing more healthy tissue COPENHAGEN, Denmark and AMSTERDAM, Netherlands, May 14 /PRNewswire-FirstCall/ -- Doctors in Denmark and...

Campbell Alliance Sales Practice to Conduct Workshop at EyeForPharma SFE Europe Conference

RALEIGH, N.C., March 26 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotechnology industry, announced today that George Schmidt, Vice President in the firm's Sales Practice, will present a workshop at the EyeForPharma Sales F...

Medarex Receives Milestone Payment for Submission of Regulatory Application Requesting Approval of Golimumab (CNTO 148) in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

PRINCETON, N.J., March 20 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ) today announced that it has received a milestone payment of an undisclosed amount from its licensing partner, Centocor, Inc., for the submission of a Marketing Authorization Application to the European Medicines...

Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

HORSHAM, Pa. and KENILWORTH, N.J., March 18 /PRNewswire/ -- Centocor, Inc. and Schering-Plough Corporation (NYSE: SGP ) announced today that a Marketing Authorization Application (MAA) has been submitted to the European Medicines Agency (EMEA) requesting the approval of golimumab (CNTO 148) a...

Vaccinogen's New Anti-Cancer Vaccine Commercially Available in Europe This Year

FREDERICK, Md., Feb. 27 /PRNewswire/ -- Vaccinogen, Inc. announced that its new vaccine to block colon cancer from recurring will be commercially available in Europe starting June 2008. "This makes OncoVAX(R) the world's first commercially viable vaccine for colon cancer," said Dr. Michael G...

Sensitech to Sponsor Panel Session at IQPC Cool Chain Europe 2008

SASSENHEIM, Netherlands, Jan. 9 /PRNewswire/ -- Sensitech, the global leader in cold chain visibility solutions, will sponsor "Cool Chain Integrity and Visibility - A Discussion and Review of Industry Implementation Trends and Expectations for Return on Investment" at IQPC (International Quali...

Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer

Avastin offers patients the chance to live twice as long without their disease advancing BASEL, Switzerland, Dec. 19 /PRNewswire/ -- Avastin (bevacizumab), Roche's innovative anti-cancer drug, was approved today in Europe for the first-line treatment of patients with...

Vaccinex, Inc. Announces Award of Key Patent in Europe for its Antibody Discovery Technology (ActivMab(R))

ROCHESTER, N.Y., Nov. 30 /PRNewswire/ -- Vaccinex, Inc. announced today the award of a key European patent (European Patent No. 1340088) for its antibody discovery technology platform, branded as ActivMab(R) Technology. Vaccinex is using its patented technology to discover and develop new mono...

DAIICHI SANKYO EUROPE is Applying for Approval of its New Combination Product of Olmesartan and Amlodipin

MUNICH, Germany, October 1 /PRNewswire/ -- - New Product Under Development for the Treatment of High Blood Pressure - Approval Requested in 28 European Countries DAIICHI SANKYO EUROPE GmbH has applied in 28 European countries for approval of a new antihypertensive medication. It is a fixed ...

Micromet to Present at the Sachs Associates 7th Annual Biotech in Europe Investor Forum

BETHESDA, Md., Sept. 26 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for cancer, inflammation and autoimmune diseases, today announced that Dr. Christian Itin, President and Chie...

ThalesNano Inc. Opens Own Representation in the United Kingdom and has New Distribution Agreements for Europe and India

BUDAPEST, Hungary, September 24 /PRNewswire/ -- ThalesNano Inc., a leading developer and manufacturer of flow chemistry, flow reactor technology, and hydrogenation technology solutions, announced today that it had continued to expand globally by opening a subsidiary in the United Kingdom and b...

Luminex Corporation Hosts the Fifth Annual Planet xMAP Europe 2007 Symposium

Two-Day Multiplexing Technology Symposium Brings Together Thought Leaders in Life Sciences and Clinical Diagnostics to Share Ideas and Best Practices OOSTERHOUT, Netherlands, Sept. 13 /PRNewswire-FirstCall/ -- Luminex Corporation (Nasdaq: LMNX ), the world leader in multiplexed solutions, toda...

Robust Annual Growth Through 2012 in the Age-Related Macular Degeneration Market Will Be Driven by Expanding Use of Lucentis in Europe

However, Off-Label Use of Avastin Will Take Market Share Away from Lucentis from 2012 to 2017, According to a New Report from Decision Resources WALTHAM, Mass., March 10 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcar...

Tolerx Expands Phase 3 'DEFEND' Trial of Otelixizumab in Europe

CAMBRIDGE, Mass., March 10 /PRNewswire/ -- Tolerx, Inc., today announced that DEFEND ( D urable Response Therapy E valuation F or E arly or N ew Onset Type 1 D iabetes), the Phase 3 trial of otelixizumab, an investigational novel targeted immunotherapeutic, has begun enrollment of new onset a...

Valdoxan(R) Granted Marketing Authorisation for the Treatment of Major Depressive Episodes in Europe

PARIS, January 24 /PRNewswire/ -- The European Commission has granted marketing authorisation for Servier's Valdoxan(R) /Thymanax(R) (agomelatine), the first melatonergic antidepressant for the treatment of adult patients with major depressive episodes. "There is still great scope for i...

Elsevier Introduces Breakthrough Technology Intelligence Solution for Accelerating R&D and Innovation in Europe

AMSTERDAM, January 22 /PRNewswire-FirstCall/ -- - illumin8 Combines Scientific Content From Elsevier and Other Publishers, Web and Patent Content With Intelligent Web Search Technology to Address Complex Technology and Market Landscape Questions Faster and More Easily Elsevier, t...

Life Science Alley: R&D Makes German Medical Technologies Top in Europe

BERLIN, December 8 /PRNewswire/ -- Germany is Europe's largest market for medical devices. Total industry revenue in 2007 amounted to EUR 17.3 billion - a nearly 7 percent increase on 2006 figures. Investors looking to enter the German and European markets can learn about Germany at Life Science A...
Other Tags
(Date:7/11/2014)... relationships with other group members to reduce aggression and ... the strategy for grooming activities shows a certain pattern ... the scientific journal Biology Letters . , Grooming ... practiced without ulterior motives. To be groomed has hygienic ... grooming another individual can provide access to infants, mating ...
(Date:7/11/2014)... The increased risk of kidney injury related to the ... the mass of HES molecules, according to a report ... the International Anesthesia Research Society (IARS). , The "total ... HES on cultured human renal proximal tubule cells (PTCs), ... colleagues of University Hospital Wrzburg, Austria. Other factorssuch ...
(Date:7/11/2014)... Evidence exists that cannabinoid receptor type 1 ... Ca2+ influx, and reduce neurotransmitter release. However, ... 1 can increase extracellular Ca2+ influx and ... his team, Tongji Hospital Affiliated to Tongji ... Technology, China used whole cell voltage-clamp and ...
Breaking Biology News(10 mins):Baboons groom early in the day to get benefits later 2In lab studies, hydroxyethyl starch has direct harmful effects on kidney cells 2
(Date:7/14/2014)... Wa (PRWEB) July 14, 2014 Dry eyes, ... of aging anymore. As recent research have pointed out, today’s ... from dry eyes as a result of using laptops ... or daily lives. , Because of this phenomenon, it has ... that will not just cure them from having dry eyes, ...
(Date:7/14/2014)... Cabin Chiang Mai, Asia’s leading inpatient addiction treatment centre, ... – a free comprehensive aftercare service for clients who ... they live in the world. , The Cabin firmly ... maintain their recovery after successfully completing primary treatment should ... As a chronic disease, addicts in recovery are always ...
(Date:7/14/2014)... 14, 2014 EurekaMag.com has newly published ... is a contagious liver disease that ranges in ... to a serious, lifelong illness that attacks the liver. ... have chronic Hepatitis C virus infection of which approximately ... research category covers all studies on Hepatitis C ...
(Date:7/14/2014)... According to the Boost Your Bust book review recently ... want to learn how to increase the size of their breasts ... chapters including:, , Chapter 1 – What Are ... 2 – How Natural Breast Enlargement Works , Chapter ... Chapter 4 – The Groundwork , Chapter ...
(Date:7/14/2014)... Vaginal Mesh lawsuit claims continue to ... mesh manufacturers in the U.S. District Court, Southern District ... federal complaints are pending against pelvic mesh manufacturers that ... (MDL No. 2325), and C.R. Bard, Inc., (MDL No. ... Mesh lawsuit claims pending, according to statistics from the ...
Breaking Medicine News(10 mins):Health News:Dry Eye Handbook Review | Taking Care of One’s Vision by Using Natural Methods – Vinamy.com 2Health News:Dry Eye Handbook Review | Taking Care of One’s Vision by Using Natural Methods – Vinamy.com 3Health News:The Cabin Chiang Mai Addiction Rehab Launches Industry-leading Aftercare Service 2Health News:The Cabin Chiang Mai Addiction Rehab Launches Industry-leading Aftercare Service 3Health News:EurekaMag.com Publishes 64,900 New Studies on Hepatitis C 2Health News:Boost Your Bust Book Review Exposes Jenny Bolton's Breast Enhancement Guide – Vkool.com 2Health News:Boost Your Bust Book Review Exposes Jenny Bolton's Breast Enhancement Guide – Vkool.com 3Health News:Nearly 60,000 Vaginal Mesh Lawsuit Claims Filed Against Seven Different Pelvic Mesh Manufacturers 2Health News:Nearly 60,000 Vaginal Mesh Lawsuit Claims Filed Against Seven Different Pelvic Mesh Manufacturers 3Health News:Nearly 60,000 Vaginal Mesh Lawsuit Claims Filed Against Seven Different Pelvic Mesh Manufacturers 4Health News:Nearly 60,000 Vaginal Mesh Lawsuit Claims Filed Against Seven Different Pelvic Mesh Manufacturers 5
Other Contents